Status:
COMPLETED
CONtrolled Focal Fibrous Band Release Method Study
Lead Sponsor:
Revelle Aesthetics, Inc
Conditions:
Cellulite
Eligibility:
FEMALE
21-55 years
Phase:
NA
Brief Summary
Study to evaluate the safety and effectiveness of the Avéli medical device to reduce the appearance of cellulite.
Detailed Description
Multi-center, single-arm clinical study to evaluate the safety and effectiveness of the Avéli device in reducing the appearance of cellulite.
Eligibility Criteria
Inclusion
- Moderate to severe cellulite
Exclusion
- Body Mass Index ≥30.0
Key Trial Info
Start Date :
January 7 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 4 2022
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT04743635
Start Date
January 7 2021
End Date
March 4 2022
Last Update
June 6 2023
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Site #3
Los Angeles, California, United States, 90292
2
Clinical Site #5
San Diego, California, United States, 92121
3
Clinical Site #4
San Francisco, California, United States, 94102
4
Clinical Site #2
Coral Gables, Florida, United States, 33146